In addition to an increase in OPG, antagonizing sRANKL, it has been reported that the direct effect of RANKL on preosteoclasts is altered under hyperglycemia, inhibiting osteoclast fusion [28]. This evidence concerns the gene TNFSF11 and Hyperglycemia.